Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

ASC/TMS1, a caspase-1 activating adaptor, is downregulated by aberrant methylation in human melanoma.

Guan X, Sagara J, Yokoyama T, Koganehira Y, Oguchi M, Saida T, Taniguchi S.

Int J Cancer. 2003 Nov 1;107(2):202-8.

2.
3.

Epigenetic regulation of ASC/TMS1 expression: potential role in apoptosis and inflammasome function.

Salminen A, Kauppinen A, Hiltunen M, Kaarniranta K.

Cell Mol Life Sci. 2014 May;71(10):1855-64. doi: 10.1007/s00018-013-1524-9. Epub 2013 Nov 28. Review.

PMID:
24287895
4.

Aberrant DNA methylation in malignant melanoma.

Schinke C, Mo Y, Yu Y, Amiri K, Sosman J, Greally J, Verma A.

Melanoma Res. 2010 Aug;20(4):253-65. doi: 10.1097/CMR.0b013e328338a35a. Review.

5.

TMS1/ASC: the cancer connection.

McConnell BB, Vertino PM.

Apoptosis. 2004 Jan;9(1):5-18. Review.

PMID:
14739594
6.

The role of oncogenes and growth factors in progressive melanoma-genesis.

Albino AP.

Pigment Cell Res. 1992;Suppl 2:199-218. Review. No abstract available.

PMID:
1409423
7.

[ASC and PYRIN family: novel players regulating innate immunity and apoptosis].

Sagara J.

Seikagaku. 2006 Jun;78(6):483-91. Review. Japanese. No abstract available.

PMID:
16856558
8.

Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities.

Micevic G, Theodosakis N, Bosenberg M.

Clin Epigenetics. 2017 Apr 4;9:34. doi: 10.1186/s13148-017-0332-8. eCollection 2017. Review.

Supplemental Content

Support Center